| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2027878 | Steroids | 2014 | 8 Pages |
•SRC-1 has been shown to be multifunctional potentials in the brain.•ORX downregulated SRC-1 in brain region related to smell and hearing and motor.•ORX downregulated SRC-1 in brain region related to learning and memory, cognition.•ORX downregulated SRC-1 in brain region related to neuroendocrine and reproduction.•Brain SRC-1 may serve as a novel target for the androgen-related central disorders.
Androgens including testosterone and dihydrotestosterone play important roles on brain structure and function, either directly through androgen receptor or indirectly through estrogen receptors, which need coactivators for their transcription activation. Steroid receptor coactivator-1 (SRC-1) has been shown to be multifunctional potentials in the brain, but how it is regulated by androgens in the brain remains unclear. In this study, we explored the effect of orchidectomy (ORX) on the expression of SRC-1 in the adult male mice using nickel-intensified immunohistochemistry. The results showed that ORX induced dramatic decrease of SRC-1 immunoreactivity in the olfactory tubercle, piriform cortex, ventral pallidum, most parts of the septal area, hippocampus, substantia nigra (compact part), pontine nuclei and nucleus of the trapezoid body (p < 0.01). Significant decrease of SRC-1 was noticed in the dorsal and lateral septal nucleus, medial preoptical area, dorsomedial and ventromedial hypothalamic nucleus and superior paraolivary nucleus (p < 0.05). Whereas in other regions examined, levels of SRC-1 immunoreactivity were not obviously changed by ORX (p > 0.05). The above results demonstrated ORX downregulation of SRC-1 in specific regions that have been involved in sense of smell, learning and memory, cognition, neuroendocrine, reproduction and motor control, indicating that SRC-1 play pivotal role in the mediating circulating androgenic regulation on these important brain functions. It also indicates that SRC-1 may serve as a novel target for the central disorders caused by the age-related decrease of circulating androgens.
